FDA started Initiative for DUNS Numbers of Pharmaceutical Sites
Recommendation

2/3 September 2026
Copenhagen, Denmark
When “Human Error” isn’t enough: Successful Failure Investigation
In our News from 4 September 2013, we reported about the DUNS numbers for the identification of pharmaceutical sites in Site Master Files. Usually, this applies only to companies which are located outside the EU/EEA.
Last year, the FDA also started an initiative for the DUNS numbers of companies which have to provide information about the location of their facilities to the FDA. These companies may therefore be contacted by Dun & Bradstreet personnel. According to the FDA there is no legal requirement for companies to collaborate. Nevertheless, the FDA asks for cooperation with the registration.
Please see the FDA's information entitled "Dun and Bradstreet Verification" for the details.
Related GMP News
01.07.2026EMA publishes updated Q&A on EU-US MRA - Veterinary Medicinal Products now fully covered
24.06.2026Reduced Testing a Matter of GMP or Specification?
17.06.2026FDA adopts updated ICH Q8/Q9/Q10 Questions & Answers (R5)
10.06.2026European QP Association Developments January through April 2026
15.04.2026ICH Q9 Training Package updated


